These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17420198)

  • 1. Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.
    Brahm NC; McElwain DL; Brown RC
    Am J Health Syst Pharm; 2007 Apr; 64(8):827-9. PubMed ID: 17420198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
    Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
    J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of aripiprazole and tardive dyskinesia.
    Abbasian C; Power P
    J Psychopharmacol; 2009 Mar; 23(2):214-5. PubMed ID: 18515468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.
    Sarkar R; Klein J; Krüger S
    Psychopharmacology (Berl); 2008 May; 197(4):687-8. PubMed ID: 18264798
    [No Abstract]   [Full Text] [Related]  

  • 5. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T; Perry CM
    Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole-induced movement disorder.
    Zacher JL; Hatchett AD
    Am J Psychiatry; 2006 Jan; 163(1):160-1. PubMed ID: 16390909
    [No Abstract]   [Full Text] [Related]  

  • 7. High dosage of aripiprazole-induced dysphagia.
    Lin TW; Lee BS; Liao YC; Chiu NY; Hsu WY
    Int J Eat Disord; 2012 Mar; 45(2):305-6. PubMed ID: 21541978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study.
    Casey DE; Carson WH; Saha AR; Liebeskind A; Ali MW; Jody D; Ingenito GG;
    Psychopharmacology (Berl); 2003 Apr; 166(4):391-9. PubMed ID: 12610718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined low-dose clozapine with low-dose aripiprazole in a schizophrenic patient.
    Hung GC; Chen YY
    J Psychopharmacol; 2009 Jan; 23(1):106-8. PubMed ID: 18308778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole.
    Raja M
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):107-10. PubMed ID: 16487453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose manic switch and high-dose antimanic effect and extrapyramidal symptoms by aripiprazole in a single bipolar patient.
    Park YM
    Am J Ther; 2014; 21(6):e218-20. PubMed ID: 23676345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole-related tardive dyskinesia.
    Maytal G; Ostacher M; Stern TA
    CNS Spectr; 2006 Jun; 11(6):435-9. PubMed ID: 16816781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syndrome of inappropriate antidiuretic hormone associated with aripiprazole.
    Yam FK; Jackson EA; Kwan BK
    Am J Health Syst Pharm; 2013 Dec; 70(23):2110-4. PubMed ID: 24249761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.
    Storch EA; Lehmkuhl H; Geffken GR; Touchton A; Murphy TK
    Depress Anxiety; 2008; 25(2):172-4. PubMed ID: 17340610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapyramidal side effects associated with aripiprazole coprescription in 2 patients.
    Cohen ST; Rulf D; Pies R
    J Clin Psychiatry; 2005 Jan; 66(1):135-6. PubMed ID: 15669901
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering.
    Takeuchi H; Suzuki T; Uchida H; Nakajima S; Nomura K; Kikuchi T; Manki H; Watanabe K; Kashima H
    J Clin Psychopharmacol; 2008 Oct; 28(5):540-3. PubMed ID: 18794650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
    Andrezina R; Josiassen RC; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; Iwamoto T
    Psychopharmacology (Berl); 2006 Oct; 188(3):281-92. PubMed ID: 16953381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone.
    Letmaier M; Painold A; Holl AK; Grohmann R; Vergin H
    Int J Psychiatry Clin Pract; 2012 Jun; 16(2):153-6. PubMed ID: 22211772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of antipsychotic-induced tardive dyskinesia with aripiprazole in an elderly patient with bipolar I disorder.
    Wu WY; Chan HY; Tan HK
    Acta Neuropsychiatr; 2014 Feb; 26(1):61-4. PubMed ID: 25142102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole and extrapyramidal symptoms.
    Lindsey RL; Kaplan D; Koliatsos V; Walters JK; Sandson NB
    J Am Acad Child Adolesc Psychiatry; 2003 Nov; 42(11):1268-9. PubMed ID: 14566162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.